James B. Summers

2.4k total citations
46 papers, 1.7k citations indexed

About

James B. Summers is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, James B. Summers has authored 46 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Organic Chemistry and 10 papers in Physiology. Recurrent topics in James B. Summers's work include Asthma and respiratory diseases (7 papers), Inflammatory mediators and NSAID effects (5 papers) and Chemical synthesis and pharmacological studies (4 papers). James B. Summers is often cited by papers focused on Asthma and respiratory diseases (7 papers), Inflammatory mediators and NSAID effects (5 papers) and Chemical synthesis and pharmacological studies (4 papers). James B. Summers collaborates with scholars based in United States, United Kingdom and South Korea. James B. Summers's co-authors include Daniel H. Albert, Dee W. Brooks, Patrick Young, Richard D. Dyer, Randy L. Bell, Joseph Kaminski, Steven K. Davidsen, Clint D. W. Brooks, George W. Carter and Jennifer J. Bouska and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

James B. Summers

46 papers receiving 1.7k citations

Peers

Countries citing papers authored by James B. Summers

Since Specialization

Citations

This map shows the geographic impact of James B. Summers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James B. Summers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James B. Summers more than expected).

Fields of papers citing papers by James B. Summers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James B. Summers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James B. Summers. The network helps show where James B. Summers may publish in the future.

Co-authorship network of co-authors of James B. Summers

This figure shows the co-authorship network connecting the top 25 collaborators of James B. Summers. A scholar is included among the top collaborators of James B. Summers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James B. Summers. James B. Summers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lithium chloride protects retinal neurocytes from nutrient deprivation by promoting DNA non-homologous end-joining 2009 ·Biochemical and Biophysical Research Communications ·Jing Zhuang, Li Fan, Xuan Liu, Zhiping Liu, Jianxian Lin, (unknown), Joseph Kaminski, James B. Summers, Zhichong Wang, Jian Ge, Keming Yu	15
2	TSP-1 Secreted by Bone Marrow Stromal Cells Contributes to Retinal Ganglion Cell Neurite Outgrowth and Survival 2008 ·PLoS ONE ·Keming Yu, Jian Ge, James B. Summers, Fan Li, Xuan Liu, Ping Ma, Joseph Kaminski, Jing Zhuang	42
3	Site-directed genome modification: derivatives of DNA-modifying enzymes as targeting tools 2005 ·Trends in biotechnology ·Craig J. Coates, Joseph Kaminski, James B. Summers, David J. Segal, Andrew D. Miller, Andreas F. Kolb	33
4	The controversial abscopal effect 2005 ·Cancer Treatment Reviews ·Joseph Kaminski, Eric T. Shinohara, James B. Summers, Kenneth J. Niermann, (unknown), Jeffrey P. Brousal	181
5	The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors 1998 ·Bioorganic & Medicinal Chemistry Letters ·Douglas H. Steinman, Michael L. Curtin, Robert B. Garland, Steven K. Davidsen, H. Robin Heyman, James H. Holms, Daniel H. Albert, (unknown), (unknown), Patrick A. Marcotte, Junling Li, Douglas W. Morgan, Charles W. Hutchins, James B. Summers	26
6	Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors 1998 ·Bioorganic & Medicinal Chemistry Letters ·George S. Sheppard, Alan S. Florjancic, (unknown), Lianhong Xu, Yan Guo, Steven K. Davidsen, Patrick A. Marcotte, (unknown), Daniel H. Albert, Terrance J. Magoc, Jennifer J. Bouska, (unknown), Douglas W. Morgan, James B. Summers	15
7	ABT-491, a highly potent and selective PAF antagonist, inhibits nasal vascular permeability associated with experimental allergic rhinitis in Brown Norway rats 1997 ·Inflammation Research ·Daniel H. Albert, Paul Tapang, Douglas W. Morgan, Michael L. Curtin, George S. Sheppard, Steven K. Davidsen, James B. Summers, (unknown)	6
8	Properties of ABT-299, a prodrug of A-85783, a highly potent platelet activating factor receptor antagonist. 1996 ·Journal of Pharmacology and Experimental Therapeutics ·Daniel H. Albert, Richard G. Conway, Terrance J. Magoc, Paul Tapang, (unknown), Guanglin Luo, James H. Holms, Steven K. Davidsen, James B. Summers, (unknown)	5
9	Ex Vivo Inhibition of PAF-Induced β-Thromboglobulin Release in Man by ABT-299, a Potent PAF Antagonist 1996 ·Advances in experimental medicine and biology ·Daniel H. Albert, Terrance J. Magoc, Hollis D. Kleinert, Eugene Sun, (unknown), George W. Carter, James B. Summers	1
10	ATTENUATION OF ENDOTOXIN-INDUCED PATHOPHYSIOLOGY BY A NEW POTENT PAF RECEPTOR ANTAGONIST 1996 ·Shock ·Kris T. Kruse-Elliott, Daniel H. Albert, James B. Summers, George W. Carter, Frederick J. Zimmerman, Jeffrey E. Grossman	20
11	Modulators of Leukotriene Biosynthesis and Receptor Activation 1996 ·Journal of Medicinal Chemistry ·Clint D. W. Brooks, James B. Summers	99
12	N-(Acyloxyalkyl)pyridinium Salts as Soluble Prodrugs of a Potent Platelet Activating Factor Antagonist 1994 ·Journal of Medicinal Chemistry ·(unknown), James B. Summers, Daniel H. Albert, James H. Holms, H. Robin Heyman, Terrance J. Magoc, Richard G. Conway, (unknown), George W. Carter	39
13	3-(2-(3-Pyridinyl)thiazolidin-4-oyl)indoles, a Novel Series of Platelet Activating Factor Antagonists 1994 ·Journal of Medicinal Chemistry ·George S. Sheppard, Daisy Pireh, George M. Carrera, Mark G. Bures, H. Robin Heyman, Douglas H. Steinman, (unknown), James G. Phillips, (unknown), Paul D. May, (unknown), (unknown), (unknown), Daniel H. Albert, Terrance J. Magoc, George W. Carter, James B. Summers	23
14	The 5-Lipoxygenase Inhibitory Activity of Zileuton in In Vitro and In Vivo Models of Antigen-Induced Airway Anaphylaxis 1994 ·Pulmonary Pharmacology ·(unknown), Randy L. Bell, Thomas K. Shaughnessy, James B. Summers, Dee W. Brooks, (unknown)	27
15	The properties of A-69412: A small hydrophilic 5-lipoxygenase inhibitor 1993 ·Inflammation Research ·Randy L. Bell, Jennifer B. Bouska, Patrick Young, Carmine Lanni, Joseph M. Machinist, (unknown), James B. Summers, Dee W. Brooks, (unknown)	9
16	The discovery and development of zileuton: An orally active 5-lipoxygenase inhibitor 1992 ·International Journal of Immunopharmacology ·Randy L. Bell, Patrick Young, Daniel H. Albert, Carmine Lanni, James B. Summers, Dee W. Brooks, Paul Rubin, (unknown)	99
17	Inhibition of leukotriene biosynthesis in the rat peritoneal cavity 1991 ·European Journal of Pharmacology ·Patrick Young, Randy L. Bell, Carmine Lanni, James B. Summers, Dee W. Brooks, George W. Carter	26
18	Hydroxamic acid inhibitors of 5-lipoxygenase: quantitative structure-activity relationships 1990 ·Journal of Medicinal Chemistry ·James B. Summers, Ki H. Kim, Hormoz Mazdiyasni, James H. Holms, James D. Ratajczyk, Andrew O. Stewart, Richard D. Dyer, George W. Carter	47
19	Orally active hydroxamic acid inhibitors of leukotriene biosynthesis 1988 ·Journal of Medicinal Chemistry ·James B. Summers, Bruce P. Gunn, (unknown), Hormoz Mazdiyasni, Andrew O. Stewart, Patrick Young, Andrew M. Goetze, Jennifer B. Bouska, Richard D. Dyer	42
20	Structure-activity analysis of a class of orally active hydroxamic acid inhibitors of leukotriene biosynthesis 1988 ·Journal of Medicinal Chemistry ·James B. Summers, Bruce P. Gunn, (unknown), Michael Martin, Hormoz Mazdiyasni, Andrew O. Stewart, Patrick Young, Jennifer B. Bouska, Andrew M. Goetze	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact